Abbott (ticker: ABT, exchange: New York Stock Exchange (.N))
News Release -
Abbott Promotes Executive Vice Presidents; Names Gonzalez to Board Of DirectorsABBOTT PARK, Ill., Dec 14, 2001 /PRNewswire via COMTEX/ -- Abbott Laboratories'
(NYSE: ABT) Board of Directors today elected Richard A. Gonzalez, president and
chief operating officer, Medical Products Group, and Jeffrey M. Leiden, M.D.,
Ph.D., president and chief operating officer, Pharmaceutical Products Group. Mr.
Gonzalez was also elected to Abbott's Board of Directors. Both individuals were
previously executive vice presidents for their respective functional areas.
These appointments are effective immediately.
"Rick and Jeff's appointments recognize their positions as leaders of Abbott's
two main business segments," said Miles D. White, chairman and chief executive
officer. "These positions are also reflective of the growing size of and breadth
of Abbott's health care business."
Both individuals will continue to report to Mr. White.
Mr. Gonzalez, 47, will continue to have responsibility for Abbott Diagnostics,
Hospital Products, Ross Products, Abbott HealthSystems and Corporate
Dr. Leiden, 46, will retain the responsibilities of chief scientific officer. He
will continue to have responsibility for Pharmaceutical Products, Abbott
International and Specialty Products. Dr Leiden currently serves on Abbott's
Board of Directors.
Abbott Laboratories is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals,
nutritionals and medical products, including devices and diagnostics. The
company employs 70,000 people and markets its products in more than 130
countries. In 2000, the company's sales and net earnings were $13.7 billion and
$2.8 billion, respectively, with diluted earnings per share of $1.78. Abbott's
news releases and other information are available on the company's Web site at
MAKE YOUR OPINION COUNT - Click Here
SOURCE Abbott Laboratories
CONTACT: Media, Christy Beckmann, +1-847-938-9725, or Financial
Community, John Thomas, +1-847-938-2655, both of Abbott Laboratories
/Company News On-Call: http://www.prnewswire.com/gh/cnoc/comp/110328.html
Copyright (C) 2001 PR Newswire. All rights reserved.